HITI
HITI
NASDAQ · Pharmaceuticals

High Tide Inc

$2.31
-0.06 (-2.53%)
Financial Highlights (FY 2026)
Revenue
887.55M
Net Income
-75,824,640
Gross Margin
26.0%
Profit Margin
-8.5%
Rev Growth
+18.5%
D/E Ratio
1.25
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 26.0% 26.0% 62.2% 62.2%
Operating Margin -3.4% -3.1% 14.1% 13.8%
Profit Margin -8.5% -8.1% 13.6% 12.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 887.55M 748.92M 117.29M 114.78M
Gross Profit 230.67M 194.64M 73.00M 71.43M
Operating Income -30,265,365 -22,984,413 16.56M 15.79M
Net Income -75,824,640 -57,583,474 15.94M 14.39M
Gross Margin 26.0% 26.0% 62.2% 62.2%
Operating Margin -3.4% -3.1% 14.1% 13.8%
Profit Margin -8.5% -8.1% 13.6% 12.5%
Rev Growth +18.5% +18.5% +17.8% -7.5%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 79.92M 79.92M 135.37M 127.81M
Total Equity 63.74M 63.74M 102.75M 99.11M
D/E Ratio 1.25 1.25 1.32 1.29
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 6.05M 4.85M 20.19M 19.55M
Free Cash Flow 10.06M 12.39M